Advertisement
Screener

REZOLUTE, INC. (RZLT) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number

2.8 / 5 stars · 68/120 Roast Me

REZOLUTE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number

REZOLUTE, INC. (RZLT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 12.47 million shares as of 2026-06-30, per its 10-K filed 2026-09-24.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-09-24

  • 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 12.47M shares.
  • 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 12.42M shares.
  • 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 13.16M shares.
  • 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 13.40M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, NumberShare-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed
2026-06-3012.47M shares
10-K · filed 2026-09-24
2026-03-3112.42M shares
10-Q · filed 2026-05-12
2025-12-3113.16M shares
10-Q · filed 2026-02-12
2025-09-3013.40M shares
10-Q · filed 2025-11-06
2025-06-3013.03M shares
10-K · filed 2026-09-24
2025-03-3112.63M shares
10-Q · filed 2025-05-13
2024-12-3110.97M shares
10-Q · filed 2025-02-12
2024-09-3010.78M shares
10-Q · filed 2024-11-07
2024-06-3010.89M shares
10-K · filed 2026-09-24
10.89M shares
10-K · filed 2024-09-19
2024-03-3110.91M shares
10-Q · filed 2024-05-15
2023-12-319.01M shares
10-Q · filed 2024-02-13
2023-09-309.11M shares
10-Q · filed 2023-11-13
2023-06-308.75M shares
10-K · filed 2025-09-17
8.74M shares
10-K · filed 2023-09-14
2023-03-318.78M shares
10-Q · filed 2023-05-11
2022-12-318.50M shares
10-Q · filed 2023-02-10
2022-09-308.48M shares
10-Q · filed 2022-11-09
2022-06-308.51M shares
10-K · filed 2024-09-19
2022-03-311.59M shares
10-Q · filed 2022-05-12
2021-12-311.31M shares
10-Q · filed 2022-02-09
2021-09-301.33M shares
10-Q · filed 2021-11-12
2021-06-301.28M shares
10-K · filed 2023-09-14
2021-03-31874.00K shares
10-Q · filed 2021-05-17
2020-12-31948.00K shares
10-Q · filed 2021-02-10
2020-09-30944.00K shares
10-Q · filed 2020-11-12
2020-06-30963.00K shares
10-K · filed 2022-09-15
2020-03-3148.16M shares
10-Q · filed 2020-05-14
2019-12-3148.02M shares
10-Q · filed 2020-02-12
2019-09-3046.42M shares
10-Q · filed 2019-11-14
2019-06-30277.00K shares
10-K · filed 2021-09-15
13.87K shares
10-K · filed 2019-09-10
2019-03-3116.87M shares
10-Q · filed 2019-05-10
2018-12-3118.70M shares
10-Q · filed 2019-02-14
2018-09-3018.84M shares
10-Q · filed 2018-12-14
2018-06-30388.00K shares
10-K · filed 2020-10-13
19.42M shares
10-K · filed 2018-10-15
2018-03-3120.81M shares
10-Q · filed 2018-05-15
2017-12-3121.09M shares
10-Q · filed 2018-02-14
2017-09-3021.40M shares
10-Q · filed 2017-11-14
2017-06-3021.29K shares
10-K · filed 2019-09-10
21.29M shares
10-K · filed 2017-09-22
2016-06-308.95M shares
10-K · filed 2018-10-15
2015-06-308.70M shares
10-K · filed 2017-09-22
2014-06-304.34M shares
10-K · filed 2014-09-30
2014-03-314.19M shares
10-Q · filed 2014-05-14
2013-12-319.05M shares
10-Q · filed 2014-02-13
2013-09-309.05M shares
10-Q · filed 2013-11-12
2013-06-301.51M shares
10-K · filed 2014-09-30
9.05M shares
10-K · filed 2013-09-11
2013-03-319.00M shares
10-Q · filed 2013-05-15
2012-06-300.00 shares
10-K · filed 2014-09-30
2011-06-300.00 shares
10-Q · filed 2013-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Turn Therapeutics Inc. (TTRX)United States$0.397B-25.68
GALECTIN THERAPEUTICS INC (GALT)United States$0.399B-11.06
Arcturus Therapeutics Holdings Inc. (ARCT)$0.402B-2.05
Opus Genetics, Inc. (IRD)United States$0.406B-3.16
RELMADA THERAPEUTICS, INC. (RLMD)United States$0.406B-11.92
Vogenx, Inc. (VOGX)United States$0.355B
ARS Pharmaceuticals, Inc. (SPRY)United States$0.414B-3.70
Atea Pharmaceuticals, Inc. (AVIR)United States$0.414B-2.26
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43